Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

CorMedix, Inc.

AMEX: CRMDHealthcare / Biotechnology / USA
1.50-0.10-6.25%Vol 1 777 4981Y Perf 154.24%
Dec 12th, 2018 16:00
BID1.52 ASK1.53
Open1.60 Previous Close1.60
Pre-Market1.62 After-Trading1.50
 0.02 1.25%  - -%
Target Price
4.50 
Analyst Rating
Strong Buy 1.00
Potencial %
200.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)158 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
59.64 
Earnings Date
15th Nov 2018

Today's Price Range

1.461.62

 

52wk Range

0.172.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
32.23%
3 Months
175.86%
6 Months
471.43%
1 Year
154.24%
3 Years
-13.04%
5 Years
100.00%

Quotes

Name / TickerPriceChg.Chg.%
CRMD1.50-0.1000-6.25
AAPL169.100.47000.28
GOOG1 063.6811.93001.13
MSFT109.080.49000.45
XOM76.02-0.6600-0.86
WFC47.74-0.0200-0.04
JNJ147.100.60000.41
FB144.502.42001.70
GE6.71-0.0500-0.74
JPM101.020.65000.65
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.40
Current Ratio
0.40
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-8 390.40
Leverage Ratio -4.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
37.20
EBIT Margin
-7 923.40
EBITDA Margin
-7 909.80
Pre-tax Profit Margin
-99 381.60
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
60.71
PS Ratios
344.10
Price to Cash Flow
-
Price to Free Cash Flow
-7.10
Cash Flow Per Share
-0.30
Price to Tangible Book
-17.96
Book Value per Share
-0.09
Enterprise Value (in ths.)
164 159
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-194.26
ROE last 12 Months
-44 174.40
Return on Assets (5Y Avg)
-193.98
ROA last 12 Months
-357.54
Return on Capital (5Y Avg)
-
ROC last 12 Months
-44 227.50
Return on invested Capital Q
-253.90
Return on invested Capital Y
-264.85
Assets Turnover
0.00
Receivables Turnover
1.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
496
Revenue per Share
0.00
Revenue Growth 3 Years
25.42
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.06-0.11-83.33
Q02 2018-0.10-0.100.00
Q01 2018-0.10-0.14-40.00
Q04 2017--0.15-
Q02 2017-0.16-0.1412.50
Q01 2017-0.15-0.19-26.67
Q04 2016-0.22-0.1627.27
Q03 2016-0.16-0.23-43.75
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.08-60.00Negative
12/2018 FY-0.38-18.75Negative
3/2019 QR-0.07-75.00Negative
12/2019 FY-0.24-71.43Negative
Next Report Date-
Estimated EPS Next Report-0.06
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume1 777 498
Shares Outstanding (in ths.)105 310
Trades Count3 190
Dollar Volume2 516 994
Avg. Volume2 774 780
Avg. Weekly Volume4 667 299
Avg. Monthly Volume2 923 125
Avg. Quarterly Volume3 972 281

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

63%37%

Bearish Bullish

56%44%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News